Literature DB >> 1415096

Is rectal biopsy necessary in irritable bowel syndrome?

D G MacIntosh1, W G Thompson, D G Patel, R Barr, M Guindi.   

Abstract

Many physicians obtain a rectal biopsy from patients with irritable bowel syndrome (IBS) in order to exclude melanosis coli and collagenous or microscopic colitis. To determine the value of routine rectal biopsy in IBS, 89 patients and 59 controls were administered a bowel questionnaire, and a rectal biopsy was obtained at sigmoidoscopy. IBS patients were 82% female and averaged 44 yr. Eighty-nine percent fulfilled three or more Manning criteria, and 84% fulfilled the Rome criteria for IBS. The 59 control subjects were 37% female, and averaged 57 yr. Only 15% fulfilled three or more Manning criteria, and 5% the Rome criteria. The 148 rectal biopsies were examined histologically by a pathologist whose methods were validated by a second pathologist. Although minor changes previously reported with phosphate enemas were observed, not a single subject had melanosis coli or fulfilled criteria for microscopic or collagenous colitis. Thus, patients with an endoscopically normal colon and a diagnosis of IBS made by established criteria are unlikely to have histologic abnormalities in the rectum. Rectal biopsies are costly and unnecessary in the investigation of IBS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415096

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 2.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

3.  The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.

Authors:  William D Chey; Borko Nojkov; Joel H Rubenstein; Richard R Dobhan; Joel K Greenson; Brooks D Cash
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

Review 4.  Irritable bowel syndrome. Diagnosis in the managed care era.

Authors:  G F Longstreth
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

5.  Clear cell colitis: a form of microscopic colitis in children.

Authors:  Jan Józefczuk; Bogdan Marian Wozniewicz
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 6.  Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants.

Authors:  W G Paterson; W G Thompson; S J Vanner; T R Faloon; W W Rosser; R W Birtwhistle; J L Morse; T A Touzel
Journal:  CMAJ       Date:  1999-07-27       Impact factor: 8.262

Review 7.  Influence of treatment on morphological features of mucosal inflammation.

Authors:  K Geboes; I Dalle
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

8.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 9.  Management of irritable bowel syndrome.

Authors:  M C Gunn; A A Cavin; J C Mansfield
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

Review 10.  Advances in the management of irritable bowel syndrome.

Authors:  Brooks D Cash; William D Chey
Journal:  Curr Gastroenterol Rep       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.